Trial Profile
The effect of regular exercise and regular exercise with teneligliptin on plasma GLP-1 concetration in the elderly patients with type 2 diabetes
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2017
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 08 Sep 2017 Status changed from recruiting to discontinued.
- 18 Nov 2013 New trial record